Boston Scientific (BSX) Completes First Case With Its PFA System

Boston Scientific (BSX) recently announced the completion of the first commercial cases in the United States with its FDA-approved Farapulse Pulsed Field Ablation (PFA) system.In January 2024, the company received the FDA clearance for the Farapulse PFA System. This made Boston Scientific the second company to have received an FDA nod for PFA for treating AFib.With the approval, Farapulse can be used to treat drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation in the isolation of pulmonar ...